Community 365 Roundtable Meeting on Improving Access to Genomic Tumour Testing Across Europe

On Tuesday 3 October at 14:30 - 17:00 CET, the European Cancer Organisation will hold the third Community 365 Roundtable event of 2023, on the subject of improving access to genomic tumour testing across Europe

 

The meeting will be co-chaired by Patrycja Rzadkowska, ECO PAC Member and Patient Advocate for Pancreatic Cancers Europe and Mark Lawler, ECO Board Member and Chair in Translational Cancer Genomics, Queen's University Belfast.

03 October 2023 14:30 - 17:00 CET

Virtual

 Apply for Registration

The programme of the event will be shared in the coming weeks! In the meantime, we invite you to register using the relevant button at the top of the page.

Speakers

  • Patrycja Rzadkowska Patient Advisory Committee Member, European Cancer Organisation, and Vice-Chair, Pancreatic Cancer Europe
  • Mark Lawler Board Member, European Cancer Organisation, and Chair, Translational Cancer Genomics, Queen's University Belfast

Speakers

  • Patrycja Rzadkowska Patient Advisory Committee Member, European Cancer Organisation, and Vice-Chair, Pancreatic Cancer Europe
  • Mark Lawler Board Member, European Cancer Organisation, and Chair, Translational Cancer Genomics, Queen's University Belfast
  • Patrycja Rzadkowska Patient Advisory Committee Member, European Cancer Organisation, and Vice-Chair, Pancreatic Cancer Europe
  • Mark Lawler Board Member, European Cancer Organisation, and Chair, Translational Cancer Genomics, Queen's University Belfast

Speakers

  • Patrycja Rzadkowska Patient Advisory Committee Member, European Cancer Organisation, and Vice-Chair, Pancreatic Cancer Europe
  • Mark Lawler Board Member, European Cancer Organisation, and Chair, Translational Cancer Genomics, Queen's University Belfast

Speakers

  • Patrycja Rzadkowska Patient Advisory Committee Member, European Cancer Organisation, and Vice-Chair, Pancreatic Cancer Europe
  • Mark Lawler Board Member, European Cancer Organisation, and Chair, Translational Cancer Genomics, Queen's University Belfast